Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (UNAUDITED)

v3.22.2.2
CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (UNAUDITED) - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-In Capital
Retained Earnings (Accumulated Deficit)
Beginning Balance at Dec. 31, 2020 $ 124,476 $ 11,223 $ 104,072 $ 9,181
Beginning Balance (in shares) at Dec. 31, 2020   15,359    
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net (loss) income (18,537)     (18,537)
Vesting of restricted stock (100) $ (9) (91)  
Vesting of restricted stock (in shares)   158    
Stock-based compensation expense 313 $ 31 282  
Ending Balance at Mar. 31, 2021 106,152 $ 11,245 104,263 (9,356)
Ending Balance (in shares) at Mar. 31, 2021   15,517    
Beginning Balance at Dec. 31, 2020 124,476 $ 11,223 104,072 9,181
Beginning Balance (in shares) at Dec. 31, 2020   15,359    
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net (loss) income (15,978)      
Ending Balance at Sep. 30, 2021 109,570 $ 11,331 105,036 (6,797)
Ending Balance (in shares) at Sep. 30, 2021   15,552    
Beginning Balance at Mar. 31, 2021 106,152 $ 11,245 104,263 (9,356)
Beginning Balance (in shares) at Mar. 31, 2021   15,517    
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net (loss) income (2,829)     (2,829)
Vesting of restricted stock (8) $ (1) (7)  
Vesting of restricted stock (in shares)   18    
Stock-based compensation expense 364 $ 37 327  
Ending Balance at Jun. 30, 2021 103,679 $ 11,281 104,583 (12,185)
Ending Balance (in shares) at Jun. 30, 2021   15,535    
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net (loss) income 5,388     5,388
Vesting of restricted stock (in shares)   17    
Stock-based compensation expense 503 $ 50 453  
Ending Balance at Sep. 30, 2021 109,570 $ 11,331 105,036 (6,797)
Ending Balance (in shares) at Sep. 30, 2021   15,552    
Beginning Balance at Dec. 31, 2021 $ 103,908 $ 11,384 105,511 (12,987)
Beginning Balance (in shares) at Dec. 31, 2021 15,622 15,622    
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net (loss) income $ (5,027)     (5,027)
Vesting of restricted stock (59) $ (6) (53)  
Vesting of restricted stock (in shares)   153    
Stock-based compensation expense 571 $ 57 514  
Ending Balance at Mar. 31, 2022 99,393 $ 11,435 105,972 (18,014)
Ending Balance (in shares) at Mar. 31, 2022   15,775    
Beginning Balance at Dec. 31, 2021 $ 103,908 $ 11,384 105,511 (12,987)
Beginning Balance (in shares) at Dec. 31, 2021 15,622 15,622    
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net (loss) income $ (3,901)      
Ending Balance at Sep. 30, 2022 $ 101,350 $ 11,518 106,720 (16,888)
Ending Balance (in shares) at Sep. 30, 2022 15,923 15,923    
Beginning Balance at Mar. 31, 2022 $ 99,393 $ 11,435 105,972 (18,014)
Beginning Balance (in shares) at Mar. 31, 2022   15,775    
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net (loss) income 528     528
Vesting of restricted stock (62) $ (6) (56)  
Vesting of restricted stock (in shares)   148    
Stock-based compensation expense 489 $ 49 440  
Ending Balance at Jun. 30, 2022 100,348 $ 11,478 106,356 (17,486)
Ending Balance (in shares) at Jun. 30, 2022   15,923    
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net (loss) income 598     598
Stock-based compensation expense 404 $ 40 364  
Ending Balance at Sep. 30, 2022 $ 101,350 $ 11,518 $ 106,720 $ (16,888)
Ending Balance (in shares) at Sep. 30, 2022 15,923 15,923